IDENIX PHARMACEUTICALS INC's ticker is IDIX and the CUSIP is 45166R204. A total of 98 filers reported holding IDENIX PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 5,050,100 | $30,200,000 | 11.31% |
| Baupost Group | 36,910,868 | $220,727,000 | 6.25% |
| Cormorant Asset Management, LP | 2,925,000 | $17,492,000 | 5.08% |
| Bain Capital Public Equity Management, LLC | 13,115,858 | $78,433,000 | 2.22% |
| 12 West Capital Management LP | 1,782,100 | $10,657,000 | 1.70% |
| BRIDGER MANAGEMENT, LLC | 2,250,000 | $13,455,000 | 0.94% |
| Old West Investment Management, LLC | 131,666 | $787,000 | 0.48% |
| GENERAL AMERICAN INVESTORS CO INC | 858,979 | $5,137,000 | 0.42% |
| BB BIOTECH AG | 1,250,000 | $7,475,000 | 0.40% |
| Aris Wealth Services, Inc. | 30,000 | $179,000 | 0.30% |